Vasundhara Rasy, a company in the Pharmaceuticals industry, reported revenue of ₹4.04 crore and net profit of ₹0.04 crore for the September 2026 quarter.
Vasundhara Rasy. (BSE: VRL) closed at ₹117.95 on 20 Nov 2026, down 44.6% over the past year. Its market capitalisation is ₹37 crore and it trades at 9.6 times earnings.
Incorporated in 1987, Vasundhara Rasayans Ltd is a manufacturer and exporter of Antacids
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.